Skip to main content

Table 1 Acceptance rate of testicular prostheses in unselected cohort of GCT patients

From: Testicular prostheses in patients with testicular cancer - acceptance rate and patient satisfaction

 

Total

With prosthesis

 

n (%)

n (%)

95% CI

Total sample

475 (100)

128 (26.9)

23.0%; 31.2%

Histology*

  Seminoma

293 (100)

81 (27.6)

22.6%; 33.1%

  Nonseminoma

182 (100)

47 (25.8)

19.6%; 32.8%

Clinical stage**

  CS1

313 (100)

91 (29.1)

24.1%; 24.4%

  CS 2

138 (100)

32 (23.2)

16.4%; 31.1%

  CS 3

24 (100)

5 (20.8)

7.1%; 42.2%

Age at diagnosis §

  ≤20 years

16 (100)

4 (25.0)

7.3%; 52.2%

  >20 - ≤ 30 years

103 (100)

34 (33.0)

24.1%; 43.0%

  >30 - ≤ 40 years

206 (100)

61 (29.6)

23.5%; 36.4%

  >40 - ≤ 50 years

113 (100)

25 (22.1)

14.9%; 30.9%

  >50 - ≤ 60 years

37 (100)

4 (10.8)

3.0%; 25.4%

Treatment #

  1997 - 2003

143 (100)

35 (24.5)

17.7%; 32.4%

  2004 – 2009

167 (100)

55 (32.9)

25.9%; 40.6%

  2010 – 2014

165 (100)

38 (23.0)

16.8%; 30.2%

  1. *histology: chi-square test p = 0.66.
  2. **clinical stage: Cochran-Armitage Trend Test p = 0.07.
  3. §age at diagnosis: Cochran-Armitage Trend Test p = 0.006, significant.
  4. #episode of treatment: Cochran-Armitage Trend Test p = 0.38.
  5. CI 95% confidence intervals.